Home2020/05 May 5, 2020 -

https://mysicklefamilyllc.com/wp-content/uploads/2020/05/shutterstock_114250597-1280x720.jpg

The U.S. National Institutes of Health (NIH) has awarded researchers at Rice University a four-year, $2.45-million grant to support the development of a CRISPR/Cas9-based gene editing treatment for sickle cell disease (SCD). Funding preclinical research, the R01 grant seeks to advance a way to modify the stem cells responsible for producing damaged blood cells in SCD patients. SCD is caused by a single mutation in the HBB gene, which codes for the beta subunit of...